N

NanoString Technologies Inc
OTC:NSTGQ

Watchlist Manager
NanoString Technologies Inc
OTC:NSTGQ
Watchlist
Price: 0.0718 USD -0.42%
Market Cap: $3.5m

NanoString Technologies Inc
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

NanoString Technologies Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
N
NanoString Technologies Inc
OTC:NSTGQ
Income from Continuing Operations
-$166.4m
CAGR 3-Years
-38%
CAGR 5-Years
-44%
CAGR 10-Years
-20%
Thermo Fisher Scientific Inc
NYSE:TMO
Income from Continuing Operations
$6.9B
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Income from Continuing Operations
$3.7B
CAGR 3-Years
-14%
CAGR 5-Years
-5%
CAGR 10-Years
8%
Waters Corp
NYSE:WAT
Income from Continuing Operations
$642.6m
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
3%
Agilent Technologies Inc
NYSE:A
Income from Continuing Operations
$1.3B
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
11%
IQVIA Holdings Inc
NYSE:IQV
Income from Continuing Operations
$1.3B
CAGR 3-Years
7%
CAGR 5-Years
35%
CAGR 10-Years
13%
No Stocks Found

NanoString Technologies Inc
Glance View

NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. The company is headquartered in Seattle, Washington and currently employs 766 full-time employees. The company went IPO on 2013-06-26. Its core technology includes chemistries that enable the labeling and counting of single molecules. The single-molecule chemistries enable the direct detection, identification, and quantification of individual target molecules in biological samples by attaching molecular reporters to each target molecule of interest. The company uses its core technology to develop tools for scientific and clinical research. The company offers two product platforms, including nCounter Analysis System, and its GeoMx Digital Spatial Profiler (GeoMx DSP) systems. The nCounter Analysis System is used to analyze the activity of genes in a single experiment and is also used by clinicians to analyze gene activity relevant for diagnostic applications. The GeoMx DSP is used to facilitate the analysis of selected regions of a biological sample to see how gene activity vary across those regions or in certain cell types.

NSTGQ Intrinsic Value
Not Available
N

See Also

What is NanoString Technologies Inc's Income from Continuing Operations?
Income from Continuing Operations
-166.4m USD

Based on the financial report for Sep 30, 2023, NanoString Technologies Inc's Income from Continuing Operations amounts to -166.4m USD.

What is NanoString Technologies Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-20%

Over the last year, the Income from Continuing Operations growth was -15%. The average annual Income from Continuing Operations growth rates for NanoString Technologies Inc have been -38% over the past three years , -44% over the past five years , and -20% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett